posted on 2024-01-19, 21:16authored byThomas W. Lyons, Isabelle Nathalie-Marie Leibler, Cyndi Qixin He, Surendra Gadamsetty, Gregorio J. Estrada, Abigail G. Doyle
A broad survey of heterogeneous hydrogenation catalysts
has been
conducted for the reduction of heterocycles commonly found in pharmaceuticals.
The comparative reactivity of these substrates is reported as a function
of catalyst, temperature, and hydrogen pressure. This analysis provided
several catalysts with complementary reactivity between substrates.
We then explored a series of bisheterocyclic substrates that provided
an intramolecular competition of heterocycle hydrogenation reactivity.
In several cases, complete selectivity could be achieved for reduction
of one heterocycle and isolated yields are reported. A general trend
in reactivity is inferred in which quinoline is the most reactive,
followed by pyrazine, then pyrrole and with pyridine being the least
reactive.